New therapies for hepatitis delta virus infection Article Swipe
Dimitri Loureiro
,
Corinne Castelnau
,
Issam Tout
,
Nathalie Boyer
,
Stéphanie Narguet
,
Sabrina Menasria Benazzouz
,
Zeina Louis
,
Nathalie Pons‐Kerjean
,
Nathalie Giuly
,
Patrick Marcellin
,
Abdellah Mansouri
,
Tarik Asselah
·
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1111/liv.14838
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1111/liv.14838
Hepatitis delta virus (HDV) infection is a defective virus requiring hepatitis B virus (HBV) for its complete replication cycle. HDV is a small hepatotropic RNA virus and around 15 to 25 million people worldwide are living with chronic hepatitis delta (CHD) infection. However, the prevalence of HDV may be underestimated, and screening is frequently insufficient. HDV infection remains endemic in several regions including Central and West Africa, the Mediterranean basin, the Middle East, Eastern Europe, Northern Asia, certain areas of Southeast Asia and the Amazon basin of South America. The best preventive strategy to decrease HDV infection is to improve coverage of the prophylactic HBV vaccine. HDV infection may occur by HBV‐HDV co‐infection or superinfection, and the latter is usually more severe. CHD is associated with a higher risk of cirrhosis and hepatocellular carcinoma (HCC) compared to HBV mono‐infection. Pegylated interferon alpha (PEG‐IFNα) therapy is limited by moderate effectiveness (around 20%) and its adverse effects. The entry inhibitor, bulevirtide (BLV, Hepcludex ® ), which was recently approved in Europe at a dose of 2 mg in sub‐cutaneous injection per day, is indicated for the treatment of CHD in adult patients with compensated liver disease and positive HDV viremia. BLV can be administrated in monotherapy or in combination with PEG‐IFNα. Nucleos(t)ide analogues can be used in combination for underlying HBV infection. The optimal treatment duration has not yet been determined and treatment should be continued if a clinical benefit is observed. There are other promising therapies such as IFN lambda (IFNλ) (immunomodulator), lonafarnib (prenylation inhibitor) and nucleic acid polymers (Inhibitors of HBsAg release). In this review, we will present an update on CHD and future promising treatments.
Related Topics
Concepts
Hepatocellular carcinoma
Medicine
Hepatitis D virus
Superinfection
Virology
Hepatitis D
Hepatitis B virus
Viremia
Virus
Immunology
Internal medicine
HBsAg
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1111/liv.14838
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/liv.14838
- OA Status
- bronze
- Cited By
- 27
- References
- 49
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3176586592
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3176586592Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1111/liv.14838Digital Object Identifier
- Title
-
New therapies for hepatitis delta virus infectionWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-06-01Full publication date if available
- Authors
-
Dimitri Loureiro, Corinne Castelnau, Issam Tout, Nathalie Boyer, Stéphanie Narguet, Sabrina Menasria Benazzouz, Zeina Louis, Nathalie Pons‐Kerjean, Nathalie Giuly, Patrick Marcellin, Abdellah Mansouri, Tarik AsselahList of authors in order
- Landing page
-
https://doi.org/10.1111/liv.14838Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/liv.14838Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/liv.14838Direct OA link when available
- Concepts
-
Hepatocellular carcinoma, Medicine, Hepatitis D virus, Superinfection, Virology, Hepatitis D, Hepatitis B virus, Viremia, Virus, Immunology, Internal medicine, HBsAgTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
27Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 7, 2024: 2, 2023: 4, 2022: 8, 2021: 6Per-year citation counts (last 5 years)
- References (count)
-
49Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3176586592 |
|---|---|
| doi | https://doi.org/10.1111/liv.14838 |
| ids.doi | https://doi.org/10.1111/liv.14838 |
| ids.mag | 3176586592 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/34155804 |
| ids.openalex | https://openalex.org/W3176586592 |
| fwci | 3.73357541 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000328 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Adult |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000354 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Africa, Western |
| mesh[2].qualifier_ui | Q000627 |
| mesh[2].descriptor_ui | D000998 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | therapeutic use |
| mesh[2].descriptor_name | Antiviral Agents |
| mesh[3].qualifier_ui | Q000188 |
| mesh[3].descriptor_ui | D006528 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | drug therapy |
| mesh[3].descriptor_name | Carcinoma, Hepatocellular |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D005060 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Europe |
| mesh[5].qualifier_ui | Q000188 |
| mesh[5].descriptor_ui | D006509 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | drug therapy |
| mesh[5].descriptor_name | Hepatitis B |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D006515 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Hepatitis B virus |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D003698 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Hepatitis Delta Virus |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D006801 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Humans |
| mesh[9].qualifier_ui | Q000188 |
| mesh[9].descriptor_ui | D008113 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | drug therapy |
| mesh[9].descriptor_name | Liver Neoplasms |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D013020 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | South America |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D000328 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Adult |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000354 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Africa, Western |
| mesh[13].qualifier_ui | Q000627 |
| mesh[13].descriptor_ui | D000998 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | therapeutic use |
| mesh[13].descriptor_name | Antiviral Agents |
| mesh[14].qualifier_ui | Q000188 |
| mesh[14].descriptor_ui | D006528 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | drug therapy |
| mesh[14].descriptor_name | Carcinoma, Hepatocellular |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D005060 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Europe |
| mesh[16].qualifier_ui | Q000188 |
| mesh[16].descriptor_ui | D006509 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | drug therapy |
| mesh[16].descriptor_name | Hepatitis B |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D006515 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Hepatitis B virus |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D003698 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Hepatitis Delta Virus |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D006801 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Humans |
| mesh[20].qualifier_ui | Q000188 |
| mesh[20].descriptor_ui | D008113 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | drug therapy |
| mesh[20].descriptor_name | Liver Neoplasms |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D013020 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | South America |
| type | review |
| title | New therapies for hepatitis delta virus infection |
| biblio.issue | S1 |
| biblio.volume | 41 |
| biblio.last_page | 37 |
| biblio.first_page | 30 |
| topics[0].id | https://openalex.org/T10340 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Hepatitis B Virus Studies |
| topics[1].id | https://openalex.org/T10151 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 1.0 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2721 |
| topics[1].subfield.display_name | Hepatology |
| topics[1].display_name | Hepatitis C virus research |
| topics[2].id | https://openalex.org/T12025 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9993000030517578 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2721 |
| topics[2].subfield.display_name | Hepatology |
| topics[2].display_name | Hepatitis Viruses Studies and Epidemiology |
| is_xpac | False |
| apc_list.value | 4740 |
| apc_list.currency | USD |
| apc_list.value_usd | 4740 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778019345 |
| concepts[0].level | 2 |
| concepts[0].score | 0.7219743132591248 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1148337 |
| concepts[0].display_name | Hepatocellular carcinoma |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.7129591107368469 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2908737250 |
| concepts[2].level | 5 |
| concepts[2].score | 0.6710968017578125 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q327281 |
| concepts[2].display_name | Hepatitis D virus |
| concepts[3].id | https://openalex.org/C2779617845 |
| concepts[3].level | 3 |
| concepts[3].score | 0.6470355987548828 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1563808 |
| concepts[3].display_name | Superinfection |
| concepts[4].id | https://openalex.org/C159047783 |
| concepts[4].level | 1 |
| concepts[4].score | 0.6073136329650879 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[4].display_name | Virology |
| concepts[5].id | https://openalex.org/C2776699657 |
| concepts[5].level | 5 |
| concepts[5].score | 0.6058614253997803 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q327281 |
| concepts[5].display_name | Hepatitis D |
| concepts[6].id | https://openalex.org/C2780593183 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5893427133560181 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q6844 |
| concepts[6].display_name | Hepatitis B virus |
| concepts[7].id | https://openalex.org/C2776185481 |
| concepts[7].level | 3 |
| concepts[7].score | 0.5834207534790039 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1425304 |
| concepts[7].display_name | Viremia |
| concepts[8].id | https://openalex.org/C2522874641 |
| concepts[8].level | 2 |
| concepts[8].score | 0.48842424154281616 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q808 |
| concepts[8].display_name | Virus |
| concepts[9].id | https://openalex.org/C203014093 |
| concepts[9].level | 1 |
| concepts[9].score | 0.40007323026657104 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[9].display_name | Immunology |
| concepts[10].id | https://openalex.org/C126322002 |
| concepts[10].level | 1 |
| concepts[10].score | 0.27331483364105225 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[10].display_name | Internal medicine |
| concepts[11].id | https://openalex.org/C2777410769 |
| concepts[11].level | 4 |
| concepts[11].score | 0.0716603696346283 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q2282887 |
| concepts[11].display_name | HBsAg |
| keywords[0].id | https://openalex.org/keywords/hepatocellular-carcinoma |
| keywords[0].score | 0.7219743132591248 |
| keywords[0].display_name | Hepatocellular carcinoma |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.7129591107368469 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/hepatitis-d-virus |
| keywords[2].score | 0.6710968017578125 |
| keywords[2].display_name | Hepatitis D virus |
| keywords[3].id | https://openalex.org/keywords/superinfection |
| keywords[3].score | 0.6470355987548828 |
| keywords[3].display_name | Superinfection |
| keywords[4].id | https://openalex.org/keywords/virology |
| keywords[4].score | 0.6073136329650879 |
| keywords[4].display_name | Virology |
| keywords[5].id | https://openalex.org/keywords/hepatitis-d |
| keywords[5].score | 0.6058614253997803 |
| keywords[5].display_name | Hepatitis D |
| keywords[6].id | https://openalex.org/keywords/hepatitis-b-virus |
| keywords[6].score | 0.5893427133560181 |
| keywords[6].display_name | Hepatitis B virus |
| keywords[7].id | https://openalex.org/keywords/viremia |
| keywords[7].score | 0.5834207534790039 |
| keywords[7].display_name | Viremia |
| keywords[8].id | https://openalex.org/keywords/virus |
| keywords[8].score | 0.48842424154281616 |
| keywords[8].display_name | Virus |
| keywords[9].id | https://openalex.org/keywords/immunology |
| keywords[9].score | 0.40007323026657104 |
| keywords[9].display_name | Immunology |
| keywords[10].id | https://openalex.org/keywords/internal-medicine |
| keywords[10].score | 0.27331483364105225 |
| keywords[10].display_name | Internal medicine |
| keywords[11].id | https://openalex.org/keywords/hbsag |
| keywords[11].score | 0.0716603696346283 |
| keywords[11].display_name | HBsAg |
| language | en |
| locations[0].id | doi:10.1111/liv.14838 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S206392846 |
| locations[0].source.issn | 1478-3223, 1478-3231 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1478-3223 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Liver International |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_lineage_names | Wiley |
| locations[0].license | |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/liv.14838 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Liver International |
| locations[0].landing_page_url | https://doi.org/10.1111/liv.14838 |
| locations[1].id | pmid:34155804 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Liver international : official journal of the International Association for the Study of the Liver |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/34155804 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5052524564 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-7860-8636 |
| authorships[0].author.display_name | Dimitri Loureiro |
| authorships[0].countries | FR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210130096 |
| authorships[0].affiliations[0].raw_affiliation_string | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I2799502834 |
| authorships[0].affiliations[1].raw_affiliation_string | Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[0].institutions[0].id | https://openalex.org/I1294671590 |
| authorships[0].institutions[0].ror | https://ror.org/02feahw73 |
| authorships[0].institutions[0].type | government |
| authorships[0].institutions[0].lineage | https://openalex.org/I1294671590 |
| authorships[0].institutions[0].country_code | FR |
| authorships[0].institutions[0].display_name | Centre National de la Recherche Scientifique |
| authorships[0].institutions[1].id | https://openalex.org/I4210130096 |
| authorships[0].institutions[1].ror | https://ror.org/02gn50d10 |
| authorships[0].institutions[1].type | facility |
| authorships[0].institutions[1].lineage | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210096427, https://openalex.org/I4210130096 |
| authorships[0].institutions[1].country_code | FR |
| authorships[0].institutions[1].display_name | Centre de Recherche sur l'Inflammation |
| authorships[0].institutions[2].id | https://openalex.org/I2799502834 |
| authorships[0].institutions[2].ror | https://ror.org/03jyzk483 |
| authorships[0].institutions[2].type | healthcare |
| authorships[0].institutions[2].lineage | https://openalex.org/I2799502834, https://openalex.org/I4210097159 |
| authorships[0].institutions[2].country_code | FR |
| authorships[0].institutions[2].display_name | Hôpital Beaujon |
| authorships[0].institutions[3].id | https://openalex.org/I154526488 |
| authorships[0].institutions[3].ror | https://ror.org/02vjkv261 |
| authorships[0].institutions[3].type | government |
| authorships[0].institutions[3].lineage | https://openalex.org/I154526488 |
| authorships[0].institutions[3].country_code | FR |
| authorships[0].institutions[3].display_name | Inserm |
| authorships[0].institutions[4].id | https://openalex.org/I204730241 |
| authorships[0].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[0].institutions[4].type | education |
| authorships[0].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[0].institutions[4].country_code | FR |
| authorships[0].institutions[4].display_name | Université Paris Cité |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Dimitri Loureiro |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France, Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[1].author.id | https://openalex.org/A5110446390 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Corinne Castelnau |
| authorships[1].countries | FR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210130096 |
| authorships[1].affiliations[0].raw_affiliation_string | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I2799502834 |
| authorships[1].affiliations[1].raw_affiliation_string | Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[1].institutions[0].id | https://openalex.org/I1294671590 |
| authorships[1].institutions[0].ror | https://ror.org/02feahw73 |
| authorships[1].institutions[0].type | government |
| authorships[1].institutions[0].lineage | https://openalex.org/I1294671590 |
| authorships[1].institutions[0].country_code | FR |
| authorships[1].institutions[0].display_name | Centre National de la Recherche Scientifique |
| authorships[1].institutions[1].id | https://openalex.org/I4210130096 |
| authorships[1].institutions[1].ror | https://ror.org/02gn50d10 |
| authorships[1].institutions[1].type | facility |
| authorships[1].institutions[1].lineage | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210096427, https://openalex.org/I4210130096 |
| authorships[1].institutions[1].country_code | FR |
| authorships[1].institutions[1].display_name | Centre de Recherche sur l'Inflammation |
| authorships[1].institutions[2].id | https://openalex.org/I2799502834 |
| authorships[1].institutions[2].ror | https://ror.org/03jyzk483 |
| authorships[1].institutions[2].type | healthcare |
| authorships[1].institutions[2].lineage | https://openalex.org/I2799502834, https://openalex.org/I4210097159 |
| authorships[1].institutions[2].country_code | FR |
| authorships[1].institutions[2].display_name | Hôpital Beaujon |
| authorships[1].institutions[3].id | https://openalex.org/I154526488 |
| authorships[1].institutions[3].ror | https://ror.org/02vjkv261 |
| authorships[1].institutions[3].type | government |
| authorships[1].institutions[3].lineage | https://openalex.org/I154526488 |
| authorships[1].institutions[3].country_code | FR |
| authorships[1].institutions[3].display_name | Inserm |
| authorships[1].institutions[4].id | https://openalex.org/I204730241 |
| authorships[1].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[1].institutions[4].type | education |
| authorships[1].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[1].institutions[4].country_code | FR |
| authorships[1].institutions[4].display_name | Université Paris Cité |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Corinne Castelnau |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France, Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[2].author.id | https://openalex.org/A5080990762 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-1019-3489 |
| authorships[2].author.display_name | Issam Tout |
| authorships[2].countries | FR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210130096 |
| authorships[2].affiliations[0].raw_affiliation_string | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I2799502834 |
| authorships[2].affiliations[1].raw_affiliation_string | Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[2].institutions[0].id | https://openalex.org/I1294671590 |
| authorships[2].institutions[0].ror | https://ror.org/02feahw73 |
| authorships[2].institutions[0].type | government |
| authorships[2].institutions[0].lineage | https://openalex.org/I1294671590 |
| authorships[2].institutions[0].country_code | FR |
| authorships[2].institutions[0].display_name | Centre National de la Recherche Scientifique |
| authorships[2].institutions[1].id | https://openalex.org/I4210130096 |
| authorships[2].institutions[1].ror | https://ror.org/02gn50d10 |
| authorships[2].institutions[1].type | facility |
| authorships[2].institutions[1].lineage | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210096427, https://openalex.org/I4210130096 |
| authorships[2].institutions[1].country_code | FR |
| authorships[2].institutions[1].display_name | Centre de Recherche sur l'Inflammation |
| authorships[2].institutions[2].id | https://openalex.org/I2799502834 |
| authorships[2].institutions[2].ror | https://ror.org/03jyzk483 |
| authorships[2].institutions[2].type | healthcare |
| authorships[2].institutions[2].lineage | https://openalex.org/I2799502834, https://openalex.org/I4210097159 |
| authorships[2].institutions[2].country_code | FR |
| authorships[2].institutions[2].display_name | Hôpital Beaujon |
| authorships[2].institutions[3].id | https://openalex.org/I154526488 |
| authorships[2].institutions[3].ror | https://ror.org/02vjkv261 |
| authorships[2].institutions[3].type | government |
| authorships[2].institutions[3].lineage | https://openalex.org/I154526488 |
| authorships[2].institutions[3].country_code | FR |
| authorships[2].institutions[3].display_name | Inserm |
| authorships[2].institutions[4].id | https://openalex.org/I204730241 |
| authorships[2].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[2].institutions[4].type | education |
| authorships[2].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[2].institutions[4].country_code | FR |
| authorships[2].institutions[4].display_name | Université Paris Cité |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Issam Tout |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France, Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[3].author.id | https://openalex.org/A5112181744 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Nathalie Boyer |
| authorships[3].countries | FR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210130096 |
| authorships[3].affiliations[0].raw_affiliation_string | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I2799502834 |
| authorships[3].affiliations[1].raw_affiliation_string | Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[3].institutions[0].id | https://openalex.org/I1294671590 |
| authorships[3].institutions[0].ror | https://ror.org/02feahw73 |
| authorships[3].institutions[0].type | government |
| authorships[3].institutions[0].lineage | https://openalex.org/I1294671590 |
| authorships[3].institutions[0].country_code | FR |
| authorships[3].institutions[0].display_name | Centre National de la Recherche Scientifique |
| authorships[3].institutions[1].id | https://openalex.org/I4210130096 |
| authorships[3].institutions[1].ror | https://ror.org/02gn50d10 |
| authorships[3].institutions[1].type | facility |
| authorships[3].institutions[1].lineage | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210096427, https://openalex.org/I4210130096 |
| authorships[3].institutions[1].country_code | FR |
| authorships[3].institutions[1].display_name | Centre de Recherche sur l'Inflammation |
| authorships[3].institutions[2].id | https://openalex.org/I2799502834 |
| authorships[3].institutions[2].ror | https://ror.org/03jyzk483 |
| authorships[3].institutions[2].type | healthcare |
| authorships[3].institutions[2].lineage | https://openalex.org/I2799502834, https://openalex.org/I4210097159 |
| authorships[3].institutions[2].country_code | FR |
| authorships[3].institutions[2].display_name | Hôpital Beaujon |
| authorships[3].institutions[3].id | https://openalex.org/I154526488 |
| authorships[3].institutions[3].ror | https://ror.org/02vjkv261 |
| authorships[3].institutions[3].type | government |
| authorships[3].institutions[3].lineage | https://openalex.org/I154526488 |
| authorships[3].institutions[3].country_code | FR |
| authorships[3].institutions[3].display_name | Inserm |
| authorships[3].institutions[4].id | https://openalex.org/I204730241 |
| authorships[3].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[3].institutions[4].type | education |
| authorships[3].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[3].institutions[4].country_code | FR |
| authorships[3].institutions[4].display_name | Université Paris Cité |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Nathalie Boyer |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France, Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[4].author.id | https://openalex.org/A5007197636 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Stéphanie Narguet |
| authorships[4].countries | FR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I2799502834 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210130096 |
| authorships[4].affiliations[1].raw_affiliation_string | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France |
| authorships[4].institutions[0].id | https://openalex.org/I1294671590 |
| authorships[4].institutions[0].ror | https://ror.org/02feahw73 |
| authorships[4].institutions[0].type | government |
| authorships[4].institutions[0].lineage | https://openalex.org/I1294671590 |
| authorships[4].institutions[0].country_code | FR |
| authorships[4].institutions[0].display_name | Centre National de la Recherche Scientifique |
| authorships[4].institutions[1].id | https://openalex.org/I4210130096 |
| authorships[4].institutions[1].ror | https://ror.org/02gn50d10 |
| authorships[4].institutions[1].type | facility |
| authorships[4].institutions[1].lineage | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210096427, https://openalex.org/I4210130096 |
| authorships[4].institutions[1].country_code | FR |
| authorships[4].institutions[1].display_name | Centre de Recherche sur l'Inflammation |
| authorships[4].institutions[2].id | https://openalex.org/I2799502834 |
| authorships[4].institutions[2].ror | https://ror.org/03jyzk483 |
| authorships[4].institutions[2].type | healthcare |
| authorships[4].institutions[2].lineage | https://openalex.org/I2799502834, https://openalex.org/I4210097159 |
| authorships[4].institutions[2].country_code | FR |
| authorships[4].institutions[2].display_name | Hôpital Beaujon |
| authorships[4].institutions[3].id | https://openalex.org/I154526488 |
| authorships[4].institutions[3].ror | https://ror.org/02vjkv261 |
| authorships[4].institutions[3].type | government |
| authorships[4].institutions[3].lineage | https://openalex.org/I154526488 |
| authorships[4].institutions[3].country_code | FR |
| authorships[4].institutions[3].display_name | Inserm |
| authorships[4].institutions[4].id | https://openalex.org/I204730241 |
| authorships[4].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[4].institutions[4].type | education |
| authorships[4].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[4].institutions[4].country_code | FR |
| authorships[4].institutions[4].display_name | Université Paris Cité |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Stéphanie Narguet |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France, Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[5].author.id | https://openalex.org/A5062973498 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Sabrina Menasria Benazzouz |
| authorships[5].countries | FR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210130096 |
| authorships[5].affiliations[0].raw_affiliation_string | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I2799502834 |
| authorships[5].affiliations[1].raw_affiliation_string | Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[5].institutions[0].id | https://openalex.org/I1294671590 |
| authorships[5].institutions[0].ror | https://ror.org/02feahw73 |
| authorships[5].institutions[0].type | government |
| authorships[5].institutions[0].lineage | https://openalex.org/I1294671590 |
| authorships[5].institutions[0].country_code | FR |
| authorships[5].institutions[0].display_name | Centre National de la Recherche Scientifique |
| authorships[5].institutions[1].id | https://openalex.org/I4210130096 |
| authorships[5].institutions[1].ror | https://ror.org/02gn50d10 |
| authorships[5].institutions[1].type | facility |
| authorships[5].institutions[1].lineage | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210096427, https://openalex.org/I4210130096 |
| authorships[5].institutions[1].country_code | FR |
| authorships[5].institutions[1].display_name | Centre de Recherche sur l'Inflammation |
| authorships[5].institutions[2].id | https://openalex.org/I2799502834 |
| authorships[5].institutions[2].ror | https://ror.org/03jyzk483 |
| authorships[5].institutions[2].type | healthcare |
| authorships[5].institutions[2].lineage | https://openalex.org/I2799502834, https://openalex.org/I4210097159 |
| authorships[5].institutions[2].country_code | FR |
| authorships[5].institutions[2].display_name | Hôpital Beaujon |
| authorships[5].institutions[3].id | https://openalex.org/I154526488 |
| authorships[5].institutions[3].ror | https://ror.org/02vjkv261 |
| authorships[5].institutions[3].type | government |
| authorships[5].institutions[3].lineage | https://openalex.org/I154526488 |
| authorships[5].institutions[3].country_code | FR |
| authorships[5].institutions[3].display_name | Inserm |
| authorships[5].institutions[4].id | https://openalex.org/I204730241 |
| authorships[5].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[5].institutions[4].type | education |
| authorships[5].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[5].institutions[4].country_code | FR |
| authorships[5].institutions[4].display_name | Université Paris Cité |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Sabrina Menasria Benazzouz |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France, Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[6].author.id | https://openalex.org/A5076818646 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Zeina Louis |
| authorships[6].countries | FR |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210130096 |
| authorships[6].affiliations[0].raw_affiliation_string | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I2799502834 |
| authorships[6].affiliations[1].raw_affiliation_string | Service de Pharmacie AP‐HP Hôpital Beaujon Clichy France |
| authorships[6].institutions[0].id | https://openalex.org/I1294671590 |
| authorships[6].institutions[0].ror | https://ror.org/02feahw73 |
| authorships[6].institutions[0].type | government |
| authorships[6].institutions[0].lineage | https://openalex.org/I1294671590 |
| authorships[6].institutions[0].country_code | FR |
| authorships[6].institutions[0].display_name | Centre National de la Recherche Scientifique |
| authorships[6].institutions[1].id | https://openalex.org/I4210130096 |
| authorships[6].institutions[1].ror | https://ror.org/02gn50d10 |
| authorships[6].institutions[1].type | facility |
| authorships[6].institutions[1].lineage | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210096427, https://openalex.org/I4210130096 |
| authorships[6].institutions[1].country_code | FR |
| authorships[6].institutions[1].display_name | Centre de Recherche sur l'Inflammation |
| authorships[6].institutions[2].id | https://openalex.org/I2799502834 |
| authorships[6].institutions[2].ror | https://ror.org/03jyzk483 |
| authorships[6].institutions[2].type | healthcare |
| authorships[6].institutions[2].lineage | https://openalex.org/I2799502834, https://openalex.org/I4210097159 |
| authorships[6].institutions[2].country_code | FR |
| authorships[6].institutions[2].display_name | Hôpital Beaujon |
| authorships[6].institutions[3].id | https://openalex.org/I154526488 |
| authorships[6].institutions[3].ror | https://ror.org/02vjkv261 |
| authorships[6].institutions[3].type | government |
| authorships[6].institutions[3].lineage | https://openalex.org/I154526488 |
| authorships[6].institutions[3].country_code | FR |
| authorships[6].institutions[3].display_name | Inserm |
| authorships[6].institutions[4].id | https://openalex.org/I204730241 |
| authorships[6].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[6].institutions[4].type | education |
| authorships[6].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[6].institutions[4].country_code | FR |
| authorships[6].institutions[4].display_name | Université Paris Cité |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Zeina Louis |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France, Service de Pharmacie AP‐HP Hôpital Beaujon Clichy France |
| authorships[7].author.id | https://openalex.org/A5084101299 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2415-754X |
| authorships[7].author.display_name | Nathalie Pons‐Kerjean |
| authorships[7].countries | FR |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210130096 |
| authorships[7].affiliations[0].raw_affiliation_string | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I2799502834 |
| authorships[7].affiliations[1].raw_affiliation_string | Service de Pharmacie AP‐HP Hôpital Beaujon Clichy France |
| authorships[7].institutions[0].id | https://openalex.org/I1294671590 |
| authorships[7].institutions[0].ror | https://ror.org/02feahw73 |
| authorships[7].institutions[0].type | government |
| authorships[7].institutions[0].lineage | https://openalex.org/I1294671590 |
| authorships[7].institutions[0].country_code | FR |
| authorships[7].institutions[0].display_name | Centre National de la Recherche Scientifique |
| authorships[7].institutions[1].id | https://openalex.org/I4210130096 |
| authorships[7].institutions[1].ror | https://ror.org/02gn50d10 |
| authorships[7].institutions[1].type | facility |
| authorships[7].institutions[1].lineage | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210096427, https://openalex.org/I4210130096 |
| authorships[7].institutions[1].country_code | FR |
| authorships[7].institutions[1].display_name | Centre de Recherche sur l'Inflammation |
| authorships[7].institutions[2].id | https://openalex.org/I2799502834 |
| authorships[7].institutions[2].ror | https://ror.org/03jyzk483 |
| authorships[7].institutions[2].type | healthcare |
| authorships[7].institutions[2].lineage | https://openalex.org/I2799502834, https://openalex.org/I4210097159 |
| authorships[7].institutions[2].country_code | FR |
| authorships[7].institutions[2].display_name | Hôpital Beaujon |
| authorships[7].institutions[3].id | https://openalex.org/I154526488 |
| authorships[7].institutions[3].ror | https://ror.org/02vjkv261 |
| authorships[7].institutions[3].type | government |
| authorships[7].institutions[3].lineage | https://openalex.org/I154526488 |
| authorships[7].institutions[3].country_code | FR |
| authorships[7].institutions[3].display_name | Inserm |
| authorships[7].institutions[4].id | https://openalex.org/I204730241 |
| authorships[7].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[7].institutions[4].type | education |
| authorships[7].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[7].institutions[4].country_code | FR |
| authorships[7].institutions[4].display_name | Université Paris Cité |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Nathalie Pons‐Kerjean |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France, Service de Pharmacie AP‐HP Hôpital Beaujon Clichy France |
| authorships[8].author.id | https://openalex.org/A5007270593 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Nathalie Giuly |
| authorships[8].countries | FR |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I2799502834 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210130096 |
| authorships[8].affiliations[1].raw_affiliation_string | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France |
| authorships[8].institutions[0].id | https://openalex.org/I1294671590 |
| authorships[8].institutions[0].ror | https://ror.org/02feahw73 |
| authorships[8].institutions[0].type | government |
| authorships[8].institutions[0].lineage | https://openalex.org/I1294671590 |
| authorships[8].institutions[0].country_code | FR |
| authorships[8].institutions[0].display_name | Centre National de la Recherche Scientifique |
| authorships[8].institutions[1].id | https://openalex.org/I4210130096 |
| authorships[8].institutions[1].ror | https://ror.org/02gn50d10 |
| authorships[8].institutions[1].type | facility |
| authorships[8].institutions[1].lineage | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210096427, https://openalex.org/I4210130096 |
| authorships[8].institutions[1].country_code | FR |
| authorships[8].institutions[1].display_name | Centre de Recherche sur l'Inflammation |
| authorships[8].institutions[2].id | https://openalex.org/I2799502834 |
| authorships[8].institutions[2].ror | https://ror.org/03jyzk483 |
| authorships[8].institutions[2].type | healthcare |
| authorships[8].institutions[2].lineage | https://openalex.org/I2799502834, https://openalex.org/I4210097159 |
| authorships[8].institutions[2].country_code | FR |
| authorships[8].institutions[2].display_name | Hôpital Beaujon |
| authorships[8].institutions[3].id | https://openalex.org/I154526488 |
| authorships[8].institutions[3].ror | https://ror.org/02vjkv261 |
| authorships[8].institutions[3].type | government |
| authorships[8].institutions[3].lineage | https://openalex.org/I154526488 |
| authorships[8].institutions[3].country_code | FR |
| authorships[8].institutions[3].display_name | Inserm |
| authorships[8].institutions[4].id | https://openalex.org/I204730241 |
| authorships[8].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[8].institutions[4].type | education |
| authorships[8].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[8].institutions[4].country_code | FR |
| authorships[8].institutions[4].display_name | Université Paris Cité |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Nathalie Giuly |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France, Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[9].author.id | https://openalex.org/A5013246678 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-8950-0287 |
| authorships[9].author.display_name | Patrick Marcellin |
| authorships[9].countries | FR |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210130096 |
| authorships[9].affiliations[0].raw_affiliation_string | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I2799502834 |
| authorships[9].affiliations[1].raw_affiliation_string | Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[9].institutions[0].id | https://openalex.org/I1294671590 |
| authorships[9].institutions[0].ror | https://ror.org/02feahw73 |
| authorships[9].institutions[0].type | government |
| authorships[9].institutions[0].lineage | https://openalex.org/I1294671590 |
| authorships[9].institutions[0].country_code | FR |
| authorships[9].institutions[0].display_name | Centre National de la Recherche Scientifique |
| authorships[9].institutions[1].id | https://openalex.org/I4210130096 |
| authorships[9].institutions[1].ror | https://ror.org/02gn50d10 |
| authorships[9].institutions[1].type | facility |
| authorships[9].institutions[1].lineage | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210096427, https://openalex.org/I4210130096 |
| authorships[9].institutions[1].country_code | FR |
| authorships[9].institutions[1].display_name | Centre de Recherche sur l'Inflammation |
| authorships[9].institutions[2].id | https://openalex.org/I2799502834 |
| authorships[9].institutions[2].ror | https://ror.org/03jyzk483 |
| authorships[9].institutions[2].type | healthcare |
| authorships[9].institutions[2].lineage | https://openalex.org/I2799502834, https://openalex.org/I4210097159 |
| authorships[9].institutions[2].country_code | FR |
| authorships[9].institutions[2].display_name | Hôpital Beaujon |
| authorships[9].institutions[3].id | https://openalex.org/I154526488 |
| authorships[9].institutions[3].ror | https://ror.org/02vjkv261 |
| authorships[9].institutions[3].type | government |
| authorships[9].institutions[3].lineage | https://openalex.org/I154526488 |
| authorships[9].institutions[3].country_code | FR |
| authorships[9].institutions[3].display_name | Inserm |
| authorships[9].institutions[4].id | https://openalex.org/I204730241 |
| authorships[9].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[9].institutions[4].type | education |
| authorships[9].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[9].institutions[4].country_code | FR |
| authorships[9].institutions[4].display_name | Université Paris Cité |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Patrick Marcellin |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France, Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[10].author.id | https://openalex.org/A5091230368 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-3856-5771 |
| authorships[10].author.display_name | Abdellah Mansouri |
| authorships[10].countries | FR |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I2799502834 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210130096 |
| authorships[10].affiliations[1].raw_affiliation_string | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France |
| authorships[10].institutions[0].id | https://openalex.org/I1294671590 |
| authorships[10].institutions[0].ror | https://ror.org/02feahw73 |
| authorships[10].institutions[0].type | government |
| authorships[10].institutions[0].lineage | https://openalex.org/I1294671590 |
| authorships[10].institutions[0].country_code | FR |
| authorships[10].institutions[0].display_name | Centre National de la Recherche Scientifique |
| authorships[10].institutions[1].id | https://openalex.org/I4210130096 |
| authorships[10].institutions[1].ror | https://ror.org/02gn50d10 |
| authorships[10].institutions[1].type | facility |
| authorships[10].institutions[1].lineage | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210096427, https://openalex.org/I4210130096 |
| authorships[10].institutions[1].country_code | FR |
| authorships[10].institutions[1].display_name | Centre de Recherche sur l'Inflammation |
| authorships[10].institutions[2].id | https://openalex.org/I2799502834 |
| authorships[10].institutions[2].ror | https://ror.org/03jyzk483 |
| authorships[10].institutions[2].type | healthcare |
| authorships[10].institutions[2].lineage | https://openalex.org/I2799502834, https://openalex.org/I4210097159 |
| authorships[10].institutions[2].country_code | FR |
| authorships[10].institutions[2].display_name | Hôpital Beaujon |
| authorships[10].institutions[3].id | https://openalex.org/I154526488 |
| authorships[10].institutions[3].ror | https://ror.org/02vjkv261 |
| authorships[10].institutions[3].type | government |
| authorships[10].institutions[3].lineage | https://openalex.org/I154526488 |
| authorships[10].institutions[3].country_code | FR |
| authorships[10].institutions[3].display_name | Inserm |
| authorships[10].institutions[4].id | https://openalex.org/I204730241 |
| authorships[10].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[10].institutions[4].type | education |
| authorships[10].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[10].institutions[4].country_code | FR |
| authorships[10].institutions[4].display_name | Université Paris Cité |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Abdellah Mansouri |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France, Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[11].author.id | https://openalex.org/A5009032052 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-0024-0595 |
| authorships[11].author.display_name | Tarik Asselah |
| authorships[11].countries | FR |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210130096 |
| authorships[11].affiliations[0].raw_affiliation_string | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France |
| authorships[11].affiliations[1].institution_ids | https://openalex.org/I2799502834 |
| authorships[11].affiliations[1].raw_affiliation_string | Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| authorships[11].institutions[0].id | https://openalex.org/I1294671590 |
| authorships[11].institutions[0].ror | https://ror.org/02feahw73 |
| authorships[11].institutions[0].type | government |
| authorships[11].institutions[0].lineage | https://openalex.org/I1294671590 |
| authorships[11].institutions[0].country_code | FR |
| authorships[11].institutions[0].display_name | Centre National de la Recherche Scientifique |
| authorships[11].institutions[1].id | https://openalex.org/I4210130096 |
| authorships[11].institutions[1].ror | https://ror.org/02gn50d10 |
| authorships[11].institutions[1].type | facility |
| authorships[11].institutions[1].lineage | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210096427, https://openalex.org/I4210130096 |
| authorships[11].institutions[1].country_code | FR |
| authorships[11].institutions[1].display_name | Centre de Recherche sur l'Inflammation |
| authorships[11].institutions[2].id | https://openalex.org/I2799502834 |
| authorships[11].institutions[2].ror | https://ror.org/03jyzk483 |
| authorships[11].institutions[2].type | healthcare |
| authorships[11].institutions[2].lineage | https://openalex.org/I2799502834, https://openalex.org/I4210097159 |
| authorships[11].institutions[2].country_code | FR |
| authorships[11].institutions[2].display_name | Hôpital Beaujon |
| authorships[11].institutions[3].id | https://openalex.org/I154526488 |
| authorships[11].institutions[3].ror | https://ror.org/02vjkv261 |
| authorships[11].institutions[3].type | government |
| authorships[11].institutions[3].lineage | https://openalex.org/I154526488 |
| authorships[11].institutions[3].country_code | FR |
| authorships[11].institutions[3].display_name | Inserm |
| authorships[11].institutions[4].id | https://openalex.org/I204730241 |
| authorships[11].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[11].institutions[4].type | education |
| authorships[11].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[11].institutions[4].country_code | FR |
| authorships[11].institutions[4].display_name | Université Paris Cité |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Tarik Asselah |
| authorships[11].is_corresponding | True |
| authorships[11].raw_affiliation_strings | Centre de recherche sur l'inflammation Université de Paris Inserm CNRS Paris France, Department of Hepatology AP‐HP Hôpital Beaujon Clichy France |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/liv.14838 |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | New therapies for hepatitis delta virus infection |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10340 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Hepatitis B Virus Studies |
| related_works | https://openalex.org/W2398834562, https://openalex.org/W4309412968, https://openalex.org/W1955129002, https://openalex.org/W2122593082, https://openalex.org/W1606237778, https://openalex.org/W2411055424, https://openalex.org/W4384946855, https://openalex.org/W2183585059, https://openalex.org/W3139883714, https://openalex.org/W2068770465 |
| cited_by_count | 27 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 7 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 2 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 4 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 8 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 6 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1111/liv.14838 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S206392846 |
| best_oa_location.source.issn | 1478-3223, 1478-3231 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1478-3223 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Liver International |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_lineage_names | Wiley |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/liv.14838 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Liver International |
| best_oa_location.landing_page_url | https://doi.org/10.1111/liv.14838 |
| primary_location.id | doi:10.1111/liv.14838 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S206392846 |
| primary_location.source.issn | 1478-3223, 1478-3231 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1478-3223 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Liver International |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_lineage_names | Wiley |
| primary_location.license | |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/liv.14838 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Liver International |
| primary_location.landing_page_url | https://doi.org/10.1111/liv.14838 |
| publication_date | 2021-06-01 |
| publication_year | 2021 |
| referenced_works | https://openalex.org/W2158953615, https://openalex.org/W1532220042, https://openalex.org/W3007488053, https://openalex.org/W3019175774, https://openalex.org/W2891216657, https://openalex.org/W2146936833, https://openalex.org/W3038914700, https://openalex.org/W1968671224, https://openalex.org/W1965052296, https://openalex.org/W2120426460, https://openalex.org/W1976998744, https://openalex.org/W1998780724, https://openalex.org/W1982848096, https://openalex.org/W1998961564, https://openalex.org/W2897289465, https://openalex.org/W2094174828, https://openalex.org/W2020963980, https://openalex.org/W2011951516, https://openalex.org/W2060563877, https://openalex.org/W2071993332, https://openalex.org/W2915619471, https://openalex.org/W2793907980, https://openalex.org/W2907871374, https://openalex.org/W3017499363, https://openalex.org/W3007855789, https://openalex.org/W1986388698, https://openalex.org/W2061594530, https://openalex.org/W2171299742, https://openalex.org/W1984472078, https://openalex.org/W2156213027, https://openalex.org/W2938610700, https://openalex.org/W2770913849, https://openalex.org/W2957492237, https://openalex.org/W1985307483, https://openalex.org/W2769259270, https://openalex.org/W2614006175, https://openalex.org/W2613067581, https://openalex.org/W2107830237, https://openalex.org/W2221378786, https://openalex.org/W3009378833, https://openalex.org/W3016425705, https://openalex.org/W2772996414, https://openalex.org/W2978002403, https://openalex.org/W2790029625, https://openalex.org/W2793070915, https://openalex.org/W2019828230, https://openalex.org/W2531694387, https://openalex.org/W2462362428, https://openalex.org/W2937972647 |
| referenced_works_count | 49 |
| abstract_inverted_index.2 | 174 |
| abstract_inverted_index.B | 12 |
| abstract_inverted_index.a | 7, 22, 127, 171, 236 |
| abstract_inverted_index.), | 163 |
| abstract_inverted_index.15 | 29 |
| abstract_inverted_index.25 | 31 |
| abstract_inverted_index.In | 263 |
| abstract_inverted_index.an | 269 |
| abstract_inverted_index.as | 247 |
| abstract_inverted_index.at | 170 |
| abstract_inverted_index.be | 49, 201, 213, 233 |
| abstract_inverted_index.by | 111, 147 |
| abstract_inverted_index.if | 235 |
| abstract_inverted_index.in | 60, 168, 176, 188, 203, 206, 215 |
| abstract_inverted_index.is | 6, 21, 53, 98, 119, 124, 145, 181, 239 |
| abstract_inverted_index.mg | 175 |
| abstract_inverted_index.of | 46, 80, 87, 102, 130, 173, 186, 260 |
| abstract_inverted_index.on | 271 |
| abstract_inverted_index.or | 114, 205 |
| abstract_inverted_index.to | 30, 94, 99, 137 |
| abstract_inverted_index.we | 266 |
| abstract_inverted_index.® | 162 |
| abstract_inverted_index.BLV | 199 |
| abstract_inverted_index.CHD | 123, 187, 272 |
| abstract_inverted_index.HBV | 105, 138, 219 |
| abstract_inverted_index.HDV | 20, 47, 56, 96, 107, 197 |
| abstract_inverted_index.IFN | 248 |
| abstract_inverted_index.RNA | 25 |
| abstract_inverted_index.The | 90, 156, 221 |
| abstract_inverted_index.and | 27, 51, 65, 83, 116, 132, 152, 195, 230, 255, 273 |
| abstract_inverted_index.are | 35, 242 |
| abstract_inverted_index.can | 200, 212 |
| abstract_inverted_index.for | 15, 183, 217 |
| abstract_inverted_index.has | 225 |
| abstract_inverted_index.its | 16, 153 |
| abstract_inverted_index.may | 48, 109 |
| abstract_inverted_index.not | 226 |
| abstract_inverted_index.per | 179 |
| abstract_inverted_index.the | 44, 68, 71, 84, 103, 117, 184 |
| abstract_inverted_index.was | 165 |
| abstract_inverted_index.yet | 227 |
| abstract_inverted_index.20%) | 151 |
| abstract_inverted_index.Asia | 82 |
| abstract_inverted_index.West | 66 |
| abstract_inverted_index.acid | 257 |
| abstract_inverted_index.been | 228 |
| abstract_inverted_index.best | 91 |
| abstract_inverted_index.day, | 180 |
| abstract_inverted_index.dose | 172 |
| abstract_inverted_index.more | 121 |
| abstract_inverted_index.risk | 129 |
| abstract_inverted_index.such | 246 |
| abstract_inverted_index.this | 264 |
| abstract_inverted_index.used | 214 |
| abstract_inverted_index.will | 267 |
| abstract_inverted_index.with | 37, 126, 191, 208 |
| abstract_inverted_index.(BLV, | 160 |
| abstract_inverted_index.(CHD) | 41 |
| abstract_inverted_index.(HBV) | 14 |
| abstract_inverted_index.(HCC) | 135 |
| abstract_inverted_index.(HDV) | 4 |
| abstract_inverted_index.Asia, | 77 |
| abstract_inverted_index.East, | 73 |
| abstract_inverted_index.HBsAg | 261 |
| abstract_inverted_index.South | 88 |
| abstract_inverted_index.There | 241 |
| abstract_inverted_index.adult | 189 |
| abstract_inverted_index.alpha | 142 |
| abstract_inverted_index.areas | 79 |
| abstract_inverted_index.basin | 86 |
| abstract_inverted_index.delta | 2, 40 |
| abstract_inverted_index.entry | 157 |
| abstract_inverted_index.liver | 193 |
| abstract_inverted_index.occur | 110 |
| abstract_inverted_index.other | 243 |
| abstract_inverted_index.small | 23 |
| abstract_inverted_index.virus | 3, 9, 13, 26 |
| abstract_inverted_index.which | 164 |
| abstract_inverted_index.Amazon | 85 |
| abstract_inverted_index.Europe | 169 |
| abstract_inverted_index.Middle | 72 |
| abstract_inverted_index.around | 28 |
| abstract_inverted_index.basin, | 70 |
| abstract_inverted_index.cycle. | 19 |
| abstract_inverted_index.future | 274 |
| abstract_inverted_index.higher | 128 |
| abstract_inverted_index.lambda | 249 |
| abstract_inverted_index.latter | 118 |
| abstract_inverted_index.living | 36 |
| abstract_inverted_index.people | 33 |
| abstract_inverted_index.should | 232 |
| abstract_inverted_index.update | 270 |
| abstract_inverted_index.(IFNλ) | 250 |
| abstract_inverted_index.(around | 150 |
| abstract_inverted_index.Africa, | 67 |
| abstract_inverted_index.Central | 64 |
| abstract_inverted_index.Eastern | 74 |
| abstract_inverted_index.Europe, | 75 |
| abstract_inverted_index.adverse | 154 |
| abstract_inverted_index.benefit | 238 |
| abstract_inverted_index.certain | 78 |
| abstract_inverted_index.chronic | 38 |
| abstract_inverted_index.disease | 194 |
| abstract_inverted_index.endemic | 59 |
| abstract_inverted_index.improve | 100 |
| abstract_inverted_index.limited | 146 |
| abstract_inverted_index.million | 32 |
| abstract_inverted_index.nucleic | 256 |
| abstract_inverted_index.optimal | 222 |
| abstract_inverted_index.present | 268 |
| abstract_inverted_index.regions | 62 |
| abstract_inverted_index.remains | 58 |
| abstract_inverted_index.review, | 265 |
| abstract_inverted_index.several | 61 |
| abstract_inverted_index.severe. | 122 |
| abstract_inverted_index.therapy | 144 |
| abstract_inverted_index.usually | 120 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.America. | 89 |
| abstract_inverted_index.However, | 43 |
| abstract_inverted_index.Northern | 76 |
| abstract_inverted_index.approved | 167 |
| abstract_inverted_index.clinical | 237 |
| abstract_inverted_index.compared | 136 |
| abstract_inverted_index.complete | 17 |
| abstract_inverted_index.coverage | 101 |
| abstract_inverted_index.decrease | 95 |
| abstract_inverted_index.duration | 224 |
| abstract_inverted_index.effects. | 155 |
| abstract_inverted_index.moderate | 148 |
| abstract_inverted_index.patients | 190 |
| abstract_inverted_index.polymers | 258 |
| abstract_inverted_index.positive | 196 |
| abstract_inverted_index.recently | 166 |
| abstract_inverted_index.strategy | 93 |
| abstract_inverted_index.vaccine. | 106 |
| abstract_inverted_index.viremia. | 198 |
| abstract_inverted_index.HBV‐HDV | 112 |
| abstract_inverted_index.Hepatitis | 1 |
| abstract_inverted_index.Hepcludex | 161 |
| abstract_inverted_index.Pegylated | 140 |
| abstract_inverted_index.Southeast | 81 |
| abstract_inverted_index.analogues | 211 |
| abstract_inverted_index.carcinoma | 134 |
| abstract_inverted_index.cirrhosis | 131 |
| abstract_inverted_index.continued | 234 |
| abstract_inverted_index.defective | 8 |
| abstract_inverted_index.hepatitis | 11, 39 |
| abstract_inverted_index.including | 63 |
| abstract_inverted_index.indicated | 182 |
| abstract_inverted_index.infection | 5, 57, 97, 108 |
| abstract_inverted_index.injection | 178 |
| abstract_inverted_index.observed. | 240 |
| abstract_inverted_index.promising | 244, 275 |
| abstract_inverted_index.release). | 262 |
| abstract_inverted_index.requiring | 10 |
| abstract_inverted_index.screening | 52 |
| abstract_inverted_index.therapies | 245 |
| abstract_inverted_index.treatment | 185, 223, 231 |
| abstract_inverted_index.worldwide | 34 |
| abstract_inverted_index.associated | 125 |
| abstract_inverted_index.determined | 229 |
| abstract_inverted_index.frequently | 54 |
| abstract_inverted_index.infection. | 42, 220 |
| abstract_inverted_index.inhibitor) | 254 |
| abstract_inverted_index.inhibitor, | 158 |
| abstract_inverted_index.interferon | 141 |
| abstract_inverted_index.lonafarnib | 252 |
| abstract_inverted_index.prevalence | 45 |
| abstract_inverted_index.preventive | 92 |
| abstract_inverted_index.underlying | 218 |
| abstract_inverted_index.(Inhibitors | 259 |
| abstract_inverted_index.bulevirtide | 159 |
| abstract_inverted_index.combination | 207, 216 |
| abstract_inverted_index.compensated | 192 |
| abstract_inverted_index.monotherapy | 204 |
| abstract_inverted_index.replication | 18 |
| abstract_inverted_index.treatments. | 276 |
| abstract_inverted_index.(prenylation | 253 |
| abstract_inverted_index.PEG‐IFNα. | 209 |
| abstract_inverted_index.hepatotropic | 24 |
| abstract_inverted_index.prophylactic | 104 |
| abstract_inverted_index.(PEG‐IFNα) | 143 |
| abstract_inverted_index.Mediterranean | 69 |
| abstract_inverted_index.Nucleos(t)ide | 210 |
| abstract_inverted_index.administrated | 202 |
| abstract_inverted_index.effectiveness | 149 |
| abstract_inverted_index.insufficient. | 55 |
| abstract_inverted_index.co‐infection | 113 |
| abstract_inverted_index.hepatocellular | 133 |
| abstract_inverted_index.sub‐cutaneous | 177 |
| abstract_inverted_index.superinfection, | 115 |
| abstract_inverted_index.underestimated, | 50 |
| abstract_inverted_index.mono‐infection. | 139 |
| abstract_inverted_index.(immunomodulator), | 251 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 94 |
| corresponding_author_ids | https://openalex.org/A5009032052 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 12 |
| corresponding_institution_ids | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I2799502834, https://openalex.org/I4210130096 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8100000023841858 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.92202593 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |